NeuraLace Medical Overview
- Year Founded
-
2016
- Status
-
Private
- Employees
-
7
- Latest Deal Type
-
Accelerator/Inc
- Investors
-
15
NeuraLace Medical General Information
Description
Developer of a non-opioid pain reduction system designed to relieve chronic nerve pain. The company offers non-drug pain management treatment for chronic nerve pain that provides significant and sustained relief for patients, stimulates damaged nerves with a short burst of magnetic pulses, and placed in pain clinics, where patients can go in for treatments, enabling patients to lower life-threatening risks of addiction to pain medicines and surgical complications.
Contact Information
Website
www.neuralacemedical.comCorporate Office
- 16990 Goldentop Road
- Suite 101
- San Diego, CA 92127
- United States
Corporate Office
- 16990 Goldentop Road
- Suite 101
- San Diego, CA 92127
- United States
NeuraLace Medical Timeline
NeuraLace Medical Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 9. Accelerator/Incubator | Completed | Clinical Trials - General | ||||
| 8. Later Stage VC | Completed | Clinical Trials - General | ||||
| 7. Accelerator/Incubator | 01-Jan-2022 | Completed | Clinical Trials - General | |||
| 6. Later Stage VC (Series A) | 24-Aug-2021 | Completed | Clinical Trials - General | |||
| 5. Accelerator/Incubator | 21-Jun-2019 | Completed | Clinical Trials - General | |||
| 4. Seed Round | 19-Jun-2019 | Completed | Clinical Trials - General | |||
| 3. Grant | 31-Oct-2018 | Completed | Clinical Trials - General | |||
| 2. Seed Round | 15-Mar-2017 | $2M | $2.18M | Completed | Startup | |
| 1. Capitalization | $180K | $180K | Completed | Startup |
NeuraLace Medical Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate ($) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Series A | ||||||||
| Seed-3 | ||||||||
| Seed-2 | 574,521 | $0.000100 | $0.03 | $0.46 | $0.46 | 1x | $0.46 | 2.15% |
| Seed-1 | 2,620,388 | $0.000100 | $0.02 | $0.34 | $0.34 | 1x | $0.34 | 9.8% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Opportunity Score
Calculated using Exit Type probabilities, the company’s stage, and PitchBook’s historical returns data.
Exit Type
Evaluates the likelihood of a successful exit for investors, and the most likely exit type.
NeuraLace Medical Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
NeuraLace Medical Patents
NeuraLace Medical Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| AU-2020300681-A1 | Devices, systems, and methods for non-invasive chronic pain therapy | Inactive | 03-Jul-2019 | ||
| US-11305130-B2 | Devices, systems, and methods for non-invasive chronic pain therapy | Active | 03-Jul-2019 | ||
| US-20210001139-A1 | Devices, systems, and methods for non-invasive chronic pain therapy | Active | 03-Jul-2019 | ||
| US-20230001224-A1 | Devices, systems, and methods for non-invasive chronic pain therapy | Pending | 03-Jul-2019 | ||
| EP-3993868-A4 | Devices, systems, and methods for non-invasive chronic pain therapy | Inactive | 03-Jul-2019 | A61N2/006 |
NeuraLace Medical Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
NeuraLace Medical Investors (15)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| Institute for the Global Entrepreneur | Accelerator/Incubator | |||
| ALMA Life Sciences | Venture Capital | Minority | ||
| Colibri Equity Ventures | Venture Capital | Minority | ||
| Connect (San Diego) | Accelerator/Incubator | Minority | ||
| UCSF Rosenman Institute | Accelerator/Incubator | Minority |
NeuraLace Medical FAQs
-
When was NeuraLace Medical founded?
NeuraLace Medical was founded in 2016.
-
Where is NeuraLace Medical headquartered?
NeuraLace Medical is headquartered in San Diego, CA.
-
What is the size of NeuraLace Medical?
NeuraLace Medical has 7 total employees.
-
What industry is NeuraLace Medical in?
NeuraLace Medical’s primary industry is Therapeutic Devices.
-
Is NeuraLace Medical a private or public company?
NeuraLace Medical is a Private company.
-
What is NeuraLace Medical’s current revenue?
The current revenue for NeuraLace Medical is .
-
How much funding has NeuraLace Medical raised over time?
NeuraLace Medical has raised $15.1M.
-
Who are NeuraLace Medical’s investors?
Institute for the Global Entrepreneur, ALMA Life Sciences, Colibri Equity Ventures, Connect (San Diego), and UCSF Rosenman Institute are 5 of 15 investors who have invested in NeuraLace Medical.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read blog » -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process »
